Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications
Cannabis Law Report
NOVEMBER 24, 2021
upcoming seminars). It is important to note that the most concentrated periods for stories framing safety concerns about cannabis were in 2019 ( n ?=?7) Tilray is identified in the article as “a Canadian company that sells cannabidiol (CBD) and tetrahydrocannabinol (THC) extracts to approved Australian patients for up to $420 per 25?mL
52 
Let's personalize your content